From the Guest Editors

Cancer Journal (United States)

Volumn 21, Issue 4, 2015, Pages 235-236

  Jain, Rakesh K ^a   Fukumura, Dai ^a   Duda, Dan G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; TUMOR MARKER;

ANTIANGIOGENIC THERAPY; CANCER CHEMOTHERAPY; CANCER THERAPY; EDITOR; EDITORIAL; HUMAN; MEDICAL EDUCATION; METASTASIS POTENTIAL; NEOPLASM; ONCOLOGY; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR IMMUNOLOGY; TUMOR MICROENVIRONMENT; TUMOR RESISTANCE; TUMOR VASCULARIZATION; DISEASE COURSE; IMMUNOLOGY; METASTASIS; NEOPLASMS; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

DISEASE PROGRESSION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MICROENVIRONMENT;

EID: 84938580253     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0000000000000136     Document Type: Editorial

References (7)

1. Jain RK. InMemoriam: Pietro M. Gullino (1919-2001). Cancer Res. 2001; 61:8930-1.
2. Hla T and Friesel R. In memory of Thomas Maciag. 2004;27:12.
3. Jain RK. Determinants of tumor blood flow: a review. Cancer Res. 1988;48: 2641-2658.
4. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 1987;6:559-593.
5. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987;47:3038-3050.
6. Jain RK. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst. 1989;81:570-576.
7. Jain RK. Judah Folkman, Obituary. Journal of Clinical Investigation 2008; 118:823.